Findit, Inc. Provides First Quarter Recap and Projects First Quarter Profit
Findit, Inc., a Nevada Corporation (OTC PINK:FDIT) and owner of Findit.com, a social networking platform that provides online marketing services, is providing a recap of the company business since year end 2020.
Projected Earnings for the First Quarter
Findit is projecting a profitable first quarter to 2021. The company is completing it financials and will be filing its first quarter financials on OTC Markets prior to the required filing period to remain current. The company continues to look at options to reduce costs where it makes sense, while also increasing revenue in areas that are profitable.
Exiting the CBD B2B Space
The company, which was in the CBD space in 2020 selling mainly B2B to TJ MAXX and Marshalls, was able to liquidate through barter most of its remaining inventory. The barter exchange is not recognized as revenue and will not be recognized until barter dollars are used and will be expensed simultaneously. The barter dollars received for the inventory that was written down to zero are $379,500.00. Findit is open to selling barter dollars for cash. Findit still offers CBD products through its online store, Urban CBD Collective™, which is hosted on Shopify.
Findit launched its latest version of the Findit App. The app is available in IOS and Android. We are continuing to make updates to provide users with a more fluid experience when creating and posting status updates that they are able to share from the app to their other social networking accounts. The other sites that users can share to are Facebook, Twitter, LinkedIn, Pinterest, and Parler, along with others that support sharing through DM, texting and email.
You can download the Findit App on Google and Apple.
Users on the Findit App can DM to Instagram and text and email their friends and followers. In addition to users being able to share the posts they create, a visitor to a post on Findit can also share someone’s post as well. This can be done by a visitor whether they are signed in or not, making it easier to spread posts to various platforms to have your message seen and heard by more followers and friends. A recent update on the Android version is AdMob by Google, which provides ads to display in the Findit App feed. These ads offer a revenue stream within the app that previously did not exist. AdMob is live in the Android version of the app. We are currently working on the IOS version to run AdMob there as well. The app is available in both Google and Apple App stores for download.
Findit, Inc. holdings in ClassWorx™, Inc.
Findit, Inc. was retained in a related party transaction at the end of 2020 to build out the ClassWorx.com website. Findit received one million shares of restricted common stock in Chill N Out Cryotherapy, Inc. (OTC PINK:CHNO), which filed a name change with FINRA to ClassWorx, Inc., in the first quarter of 2021. The common shares are restricted for a one-year period which runs to November of 2021. ClassWorx, Inc. retained B.F Borgers as their Auditor and the Law Firm of Thomas C. Cook to complete its audit and file a Form S1 registration statement with the S.E.C. The shares have traded in the past twelve months between 0.0002 – 0.7600 click here for current quote. The board of directors of Findit, Inc. and ClassWorx, Inc. are the same, Raymond Firth and Thomas Powers. The companies have reported in filings that this is a related party transaction. ClassWorx is a directory for hosts of virtual events through Zoom and provides hosts a way to receive receive payments from attendees through Stripe.
Findit Form S1 Filed
Findit, Inc. filed its Form S1 in 2021. The S.E.C. has issued its first comment letter. It is possible that additional comment letters could be received after Findit submits its response. The company, along with its counsel and accountant, has prepared its response and will be filing its response to the S.E.C. The Form S1 is a registration statement that, when approved, will provide Findit the opportunity to raise up to $3,000,000.00, the current offering price in the filing is at .30 cents per share. The current price of Findit is lower than the offering price in the Form S1.
Raymond Firth President stated: “We are focused on the Findit brand and bringing awareness to our technology, products and services. Our objective is to increase our market share by increasing the number of users on Findit and increasing our premium, fee-based online marketing services. We are in the extremely competitive social networking space that includes brands that are much more recognized than Findit. These brands include Facebook, Instagram, Twitter and Snapchat. With completed updates, and further improvements to the Findit app in development, we are optimistic that we can increase our membership. I’m looking forward to the potential growth of Classworx directory for people who host events virtually through Zoom and the value that can bring to Findit and our shareholders.”
Chill N Out Cryotherapy, Inc. (OTC PINK:CHNO), a Delaware Corporation, owns and operates ClassWorx.com. Chill N Out Cryotherapy, Inc. currently trades on the OTC Pinks under the stock symbol CHNO. Classworx provides an internet-based, global network-directory of people offering virtual classes and events utilizing video conferencing to remotely deliver individual or group instruction in a broad range of disciplines (“virtual classes”). The Company is based in the Atlanta, Georgia area and spans a global outreach through the worldwide web.
Findit.com is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing, and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides members the ability to post, share, and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status updates posted in Findit can be crawled by outside search engines, which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides real estate agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc. is focused on the development of monetized internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc. trades under the stock symbol FDIT on the OTC Pinksheets.
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the ‘Exchange Act’), including statements regarding potential sales, the success of the company’s business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.
Clark St. Amant
BioRegenx Announces Investor Update
CEO, William Resides announces that as of July 1st, 2022, BioRegenx has moved from due diligence to a binding letter of intent to merge with a public company. These steps also include drafting of the definitive agreement for final merger.
As part of the merger activity, BioRegenx has hired Dan Cortes, CPA as its CFO. This decision was made in part to Dan’s track record as an experienced corporate financial CFO with more than 20 years of progressive experience in financial operations and taxation with both private and public organizations ranging from startups to those with hundreds of millions in revenue.
Microvascular Health Solutions Developments
After 18-months of research and development, followed by rigorous testing, Microvascular Health Solutions has approved final production of a new camera capable of taking six times more video images gathered from under the tongue. The new patent-pending camera is called CapiVision™. The components for 1,000 CapiVision cameras have been ordered and production has begun with delivery expected late Q3, early Q4.
Along with development of the new CapiVision camera, the MVHS team has completed development of the 5.2.7 version of the GlycoCheck software and new video acquisition software that quality-check videos recorded by the CapiVision camera. Test results will be calculated on a new high-powered custom laptop computer capable of quickly processing results.
The next stage of software development is for the processing of the GlycoCheck video images to be transmitted to the cloud for calculation and storage of the MicroVascular Health Score™ as a Software as a Service (SaaS). This will run on the Microsoft™ Azure Platform. The development is ongoing with our technology team in the Netherlands and the first version is expected to be released Q4, 2022.
Our plan is to bring the GlycoCheck system now being used in over 140 academic research hospitals studying a wide range of conditions and diseases, into a much-anticipated targeted system for medical and professional office use that generates a personalized MicroVascular Health Report for individual patients. To support medical and professional office use, we have created a series of 19 GlycoCheck System training modules, with more coming in the future. Once a provider views the videos and takes a test for each module, and a passing score is completed for all modules, a certificate of completion is issued. The training platform is hosted by the Boston BioLife Academy, a leading training, CME credit, and in-person events company for MD’s and Practitioners across the U.S.
There are now 90 peer-reviewed published studies using GlycoCheck in major medical journals that have researched how diseases and conditions are linked to a decline in endothelial glycocalyx function and a leaky, compromised microvascular system. Those studies range from health issues like sepsis, COVID-19, kidney disease, heart disease, cerebrovascular events, psoriasis, and many more. View the entire list at https://glycocheck.com/research-and-studies/#published. If you have a specific disease or condition you wish to read more about, type the name in the “Search” function to narrow the studies down to your specific interest.
BioRegenx’ wholly owned subsidiary, NuLife Sciences announces the release of its latest product and service, TruEpigenetics via the Apple Store and Google Play. TruEpigenetics has launched on www.NuLifeSciences.com/TruEpigenetics. Now, you can discover your biological age and take control of your genetic health with a simple saliva test. The TruEpigenetics Practitioner and Patient on-boarding portal is expected for release in late Q3.
Referral Link Development for Sales Tracking
Currently, we are in the in final phase of testing of NuLife Sciences’ Hybrid-Direct Sales and Practitioner referral link program. This will allow all BioRegenx’ subsidiaries to utilize referral links, commission tracking, and account on-boarding for both our professional clients’ practices as well as their patients.
Endocalyx Pro™ Double-Blind Placebo Studies
Double-blind placebo studies on the effectiveness of Endocalyx Pro have been running since 2015. In-depth studies take years to complete, and we are just now seeing the results from those studies. These studies are in cell cultures, animal trials, as well as human studies. These studies are on the following health conditions and diseases:
Additional studies currently being written and in the approval process will be devoted to these conditions:
Emergency Room Admissions
Arterial Plaque Development
Review these studies and more at https://microvascular.com/endocalyx-pro-studies
BioRegenx, Inc., (https://bioregenx.com/) a holding company, consists of Microvascular Health Solutions, LLC, My Body Rx, LLC, and NuLife Sciences, Inc. BioRegenx and its subsidiaries combine the patented intellectual property of the breakthrough GlycoCheck medical testing device, the patented nutraceutical Endocalyx Pro, additional synergistic dietary supplement products sold under the My Body Rx brand, and a customer base of medical professionals and brand partners throughout North America.
Microvascular Health Solutions (MVHS) is a research and product development, sales, education, and marketing company that has developed the patented and clinically tested Endocalyx Pro™ dietary supplement to improve the health of the endothelial glycocalyx. In addition, MVHS manufactures, exclusively sells, and distributes the patented GlycoCheck™ software and Class 1 medical device that measures and analyzes the endothelial glycocalyx, a transparent lining inside all blood vessels.
My Body Rx™ is a manufacturing, sales and product development company that produces dietary supplements that complement and work synergistically with the patented and clinically tested Endocalyx Pro™ product to support and improve healthy aging and increase longevity.
NuLife Sciences, Inc. is a marketing and distribution company whose mission is to harness advanced technologies to redefine health and longevity. This is achieved by increasing understanding of the biology that controls lifespan and anti-aging in the human body. NuLife exclusively markets the My Body Rx™ supplement line. NuLife will also distribute GlycoCheck™, TruEpigenetics, and additional new products currently under consideration.
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements regarding potential sales, the success of the company’s business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of BioRegenx, Inc. to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and BioRegenx, Inc. assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customers to pay for ordered products, and political and economic risks inherent in international trade
An Unbeatable Host of Services for WMS Can Be Yours Today with WynCore
The convenience and confidence in a company that provides total services for a WMS upgrade or modification is close at hand. Unexpected demands on the supply chain have caused you to consider an upgrade or series of modifications now. The experienced consultants at WynCore provide customized warehouse management system changes from minor adjustments to a complete overhaul for Manhattan Software.
WynCore professionals provide the plan, implantation and support for your custom needs. A seamless integration, modification and upgrade or total overhaul that fits your bottom line and demanding timeline. Call now to speak with our software developers about your warehouse management software upgrade services and customization needs by calling us at 866-996-2673.
WynCore offers you a full host of services including: design and implementation, QA Testing, customized maintenance and support, along with training. Our flexible lineup of services allows us to quickly find the best solution for you. In addition, we are proud to note that WynCore developers and project management teams are experts in both Agile and Waterfall methodologies and well versed in DEV-OPS.
As the trusted and preferred choice for Manhattan software WMS modifications needed for never-ending challenges, our team can quickly design a customized set of services to assist you in operating your warehouse flawlessly. From minor tweaks and adjustments to your WMS or a complete overhaul, WynCore consultants craft a customized plan to suit your timeline and budget.
Our support to you does not stop at the end of your WMS customization services. WynCore project management and global support teams provide assistance whenever you need it to help minimize disruptions with any arising issue, even after a modification or upgrade is completed. Why wait for your WMS improvement? Call WynCore today at 866-996-2673.
WynCore Offers Complete WMS Modifications to Enhance your Manhattan Software
WynCore can meet your pressing need for the convenience of total services for a WMS upgrade or modification. Our experienced consultants offer customized warehouse management system changes from minor adjustments to a complete overhaul for Manhattan Software. Call 866-996-2673 to speak with our software developers about your warehouse management software upgrade services and customization needs.
We offer you a full host of services including: design and implementation, QA Testing, customized maintenance and support, along with training. Your warehouse management software could use small adjustments or need a major redesign where training and support are required. Our flexible lineup of services allows us to quickly find the best solution for you. In addition, we are proud to note that WynCore developers and project management teams are experts in both Agile and Waterfall methodologies and well versed in DEV-OPS.
We are the trusted and preferred choice for Manhattan software WMS modifications needed for the challenges of today and in the future. Our developers can quickly design a customized set of services to assist you in operating your warehouse flawlessly. From minor tweaks and adjustments to your WMS or a complete overhaul, WynCore professionals craft a customized plan to suit your timeline and budget.
Our support to you does not stop at the end of your WMS customization services. WynCore project management and global support teams provide assistance whenever you need it 24/7 to help minimize disruptions with any arising issue, even after a modification or upgrade is completed.
WynCore provides the plan, implementation and support especially for you. A seamless integration, modification and upgrade or total overhaul that fits your bottom line can be in your future. Reach out today and speak with our software developers about your warehouse management software upgrade services and customization needs by calling us at 866-996-2673.